Publikationen
W. Deppert, M. Kurth, M. Graessmann, A. Graessmann, and U. Knippschild. Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells. Oncogene, 1991. 6(10): p. 1931-1938.
U. Knippschild, J. Kiefer, T. Patschinsky, and W. Deppert. Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J Virol, 1991. 65(8): p. 4414-4423.
T. Patschinsky, U. Knippschild, and W. Deppert. Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells. J Virol, 1992. 66(6): p. 3846-3859.
J. Zerrahn, U. Knippschild, T. Winkler, and W. Deppert. Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. Embo J, 1993. 12(12): p. 4739-4746.
U. Knippschild, T. Kolzau, and W. Deppert. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. Oncogene, 1995. 11(4): p. 683-690.
U. Knippschild, D. Milne, L. Campbell, and D. Meek. p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. Oncogene, 1996. 13(7): p. 1387-1393.
U. Knippschild, M. Oren, and W. Deppert. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene, 1996. 12(8): p. 1755-1765.
H.W. Sturzbecher, B. Donzelmann, W. Henning, U. Knippschild, and S. Buchhop. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. Embo J, 1996. 15(8): p. 1992-2002.
W. Henning, G. Rohaly, T. Kolzau, U. Knippschild, H. Maacke, and W. Deppert. MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J Virol, 1997. 71(10): p. 7609-7618.
U. Knippschild, D.M. Milne, L.E. Campbell, A.J. DeMaggio, E. Christenson, M.F. Hoekstra, and D.W. Meek. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene, 1997. 15(14): p. 1727-1736.
D.W. Meek, L.E. Campbell, L.J. Jardine, U. Knippschild, L. McKendrick, and D.M. Milne. Multi-site phosphorylation of p53 by protein kinases inducible by p53 and DNA damage. Biochem Soc Trans, 1997. 25(2): p. 416-419.
F. Janus, N. Albrechtsen, U. Knippschild, L. Wiesmuller, F. Grosse, and W. Deppert. Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding. Mol Cell Biol, 1999. 19(3): p. 2155-2168.
L. Behrend, D.M. Milne, M. Stoter, W. Deppert, L.E. Campbell, D.W. Meek, and U. Knippschild. IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene, 2000. 19(47): p. 5303-5313.
L. Behrend, M. Stoter, M. Kurth, G. Rutter, J. Heukeshoven, W. Deppert, and U. Knippschild. Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures, microtubules and the spindle apparatus. Eur J Cell Biol, 2000. 79(4): p. 240-251.
T. Maritzen, J. Lohler, W. Deppert, and U. Knippschild. Casein kinase I delta (CKIdelta) is involved in lymphocyte physiology. Eur J Cell Biol, 2003. 82(7): p. 369-378.
J.I. Martin-Subero, U. Knippschild, L. Harder, T.F. Barth, J. Riemke, S. Grohmann, S. Gesk, J. Hoppner, P. Moller, R.M. Parwaresch, and R. Siebert. Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma? Leukemia, 2003. 17(11): p. 2214-2219.
D.W. Meek and U. Knippschild. Posttranslational modification of MDM2. Mol Cancer Res, 2003. 1(14): p. 1017-1026.
R.A. Ventura, J.I. Martin-Subero, U. Knippschild, R.D. Gascoyne, G. Delsol, D.Y. Mason, and R. Siebert. Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma. Leukemia, 2004. 18(11): p. 1910-1911.
M. Winter, D. Milne, S. Dias, R. Kulikov, U. Knippschild, C. Blattner, and D. Meek. Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry, 2004. 43(51): p. 16356-16364.
U. Knippschild, A. Gocht, S. Wolff, N. Huber, J. Lohler, and M. Stoter. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal, 2005. 17(6): p. 675-689.
U. Knippschild, S. Wolff, G. Giamas, C. Brockschmidt, M. Wittau, P.U. Wurl, T. Eismann, and M. Stoter. The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development. Onkologie, 2005. 28(10): p. 508-514.
M. Stoter, A.M. Bamberger, B. Aslan, M. Kurth, D. Speidel, T. Loning, H.G. Frank, P. Kaufmann, J. Lohler, D. Henne-Bruns, W. Deppert, and U. Knippschild. Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells. Oncogene, 2005. 24(54): p. 7964-7975.
S. Wolff, Z. Xiao, M. Wittau, N. Sussner, M. Stoter, and U. Knippschild. Interaction of casein kinase 1 delta (CK1delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A). Biochim Biophys Acta, 2005. 1745(2): p. 196-206.
S. Wolff, M. Stoter, G. Giamas, M. Piesche, D. Henne-Bruns, G. Banting, and U. Knippschild. Casein kinase 1 delta (CK1delta) interacts with the SNARE associated protein snapin. FEBS Lett, 2006. 580(27): p. 6477-6484.
G. Giamas, H. Hirner, L. Shoshiashvili, A. Grothey, S. Gessert, M. Kuhl, D. Henne-Bruns, C.E. Vorgias, and U. Knippschild. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem J, 2007. 406(3): p. 389-398.
G. Giamas, J. Stebbing, C.E. Vorgias, and U. Knippschild. Protein kinases as targets for cancer treatment. Pharmacogenomics, 2007. 8(8): p. 1005-1016.
J. von Blume, U. Knippschild, F. Dequiedt, G. Giamas, A. Beck, A. Auer, J. Van Lint, G. Adler, and T. Seufferlein. Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2. EMBO J, 2007. 26(22): p. 4619-4633.
C. Brockschmidt, H. Hirner, N. Huber, T. Eismann, A. Hillenbrand, G. Giamas, B. Radunsky, O. Ammerpohl, B. Bohm, D. Henne-Bruns, H. Kalthoff, F. Leithauser, A. Trauzold, and U. Knippschild. Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut, 2008. 57(6): p. 799-806.
U. Kintscher, M. Hartge, K. Hess, A. Foryst-Ludwig, M. Clemenz, M. Wabitsch, P. Fischer-Posovszky, T.F. Barth, D. Dragun, T. Skurk, H. Hauner, M. Bluher, T. Unger, A.M. Wolf, U. Knippschild, V. Hombach, and N. Marx. T-lymphocyte Infiltration in Visceral Adipose Tissue. A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance. Arterioscler Thromb Vasc Biol, 2008.
Grochola, L.F., Greither, T., Taubert, H., Moller, P., Knippschild, U., Udelnow, A., Henne-Bruns, D. and Wurl, P. (2008). The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br J Cancer
Grochola, L.F., Greither, T., Taubert, H.W., Moller, P., Knippschild, U., Udelnow, A., Henne-Bruns, D. and Wurl, P. (2008). Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas. Neoplasia 10, 973-6.
Michael Schmieder, Sebastian Wolf, Bettina Danner, Susanne Stöhr, Markus S Juchems, Peter Wuerl, Doris Henne-Bruns, Uwe Knippschild, Cornelia Hasel and Klaus Kramer. 2008, p16 expression differentiates high-risk GIST and predicts poor outcome. Neoplasia, Volume 10, 1154-62 Immunohistochemical Characterisation of Cell-Type Specific Expression of CK1δ in Various Tissues of Young Adult BALB / c Mice G. Giamas, L. Castellano, Q. Feng, U. Knippschild, J. Jacob, R. S. Thomas, R. C. Coombes, C. L. Smith, L. R. Jiao and J. Stebbing (2009): CK1δ modulates the transcriptional activity
|





view this abstract
